Evidence map›Paper›PMID 33661343›Full record

ArticleCalcified tissue international2021

A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM).

E Cavalier, R Eastell, N R Jørgensen, K Makris, S Tournis, S Vasikaran, J A Kanis, C Cooper, H Pottel, H A Morris and 1 more

Erratum issuedOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in Calcified tissue international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Advances in laboratory medicine · 2024
    Article
  7. Clinical use of bone markers: a challenge to variability.Advances in laboratory medicine · 2024
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 5 countries.

E CavalierDepartment of Clinical Chemistry, University of Liège, CHU Sart-Tilman, Domaine du Sart-Tilman, B-4000, Liège, Belgium. Etienne.cavalier@chu.ulg.ac.be.
R EastellMellanby Centre for Bone Research, University of Sheffield, Sheffield, UK.
N R JørgensenDepartment of Clinical Biochemistry, Rigshospitalet, 2600, Glostrup, Denmark.
K MakrisClinical Biochemistry Department, KAT General Hospital, 14561, Athens, Greece.
S TournisLaboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, University of Athens, 14561, Athens, Greece.
S VasikaranPathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, WA, 6150, Australia.
J A KanisCentre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK.
C CooperThe MRC Epidemiology Resource Centre, Southampton General Hospital, University of Southampton, Southampton, SO16 6YD, UK.
H PottelDepartment of Public Health and Primary Care, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
H A MorrisSchool of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, 5000, Australia.
IFCC-IOF Committee for Bone Metabolism (C-BM)
National and Kapodistrian University of Athens · GRAustralian Catholic University · AUFiona Stanley Hospital · AUKU Leuven · BESouthampton General Hospital · GBUniversity of Copenhagen · DKUniversity of Liège · BEUniversity of Sheffield · GBUniversity of South Australia · AU

Funding

Medical Research Council G0400491Medical Research Council MC_PC_21000Medical Research Council MC_PC_21001Medical Research Council MC_U147585819Medical Research Council MC_U147585824Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UU_12011/1Medical Research Council MR/P020941/1Versus Arthritis 17702
6 · The paper itself

Abstract

backgroundBiochemical bone turnover markers are useful tools to assess bone remodeling. C-terminal telopeptide of type I collagen (ß-CTX) has been recommended as a reference marker for bone resorption in research studies.

methodsWe describe the results of a multicenter study for routine clinical laboratory assays for ß-CTX in serum and plasma. Four centers (Athens GR, Copenhagen DK, Liege BE and Sheffield UK) collected serum and plasma (EDTA) samples from 796 patients presenting to osteoporosis clinics. Specimens were analyzed in duplicate with each of the available routine clinical laboratory methods according to the manufacturers' instructions. Passing-Bablok regressions, Bland-Altman plots, V-shape evaluation method, and Concordance correlation coefficient for ß-CTX values between serum and plasma specimens and between methods were used to determine the agreement between results. A generalized linear model was employed to identify possible variables that affected the relationship between the methods. Two pools of serum were finally prepared and sent to the four centers to be measured in 5-plicates on 5 consecutive days with the different methods.

resultsWe identified significant variations between methods and between centers although comparison results were generally more consistent in plasma compared to serum. We developed univariate linear regression equations to predict Roche Elecsys®, IDS-iSYS, or IDS ELISA ß-CTX results from any other assay and a multivariable model including the site of analysis, the age, and weight of the patient. The coefficients of determination (R

conclusionOur results show large within- and between-assay variation for ß-CTX measurement, particularly in serum. Stability of the analyte could be one of the explanations. More studies should be undertaken to overcome this problem. Until harmonization is achieved, we recommend measuring ß-CTX by the same assay on EDTA plasma, especially for research purposes in large pharmacological trials where samples can be stored for long periods before they are assayed.

Indexed as

Bone ResorptionCollagen Type IBiomarkersBone RemodelingHumansPeptide FragmentsPeptidesBiomarkersCollagen Type IPeptide FragmentsPeptidesBone resorptionBone turnover markersC-terminal telopeptide of type I collagenHarmonizationß-crosslapsß-CTX

Identifiers

PMID33661343
PMCPMC8166738
OpenAlexW3134169690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.